Cerevel Therapeutics Holdings, Inc.
CEREDelisted Aug 1, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2023
Institutional positions in Cerevel Therapeutics Holdings, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 119
- −5 vs. Q2 2023
- Shares held
- 140.8M
- +2.33M (+1.7%) vs. Q2 2023
- Total value
- $3.07B
- −$1.33B (−30.2%) vs. Q2 2023
- New holders
- 24
- 54 more added
- Sold out
- 29
- 25 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CERE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $1.16K |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 2 | $20.7K |
| Q2 2024 | 231 | $6.42B |
| Q1 2024 | 210 | $6.67B |
| Q4 2023 | 195 | $6.61B |
| Q3 2023 | 119 | $3.07B |
| Q2 2023 | 125 | $4.41B |
| Q1 2023 | 119 | $3.30B |
| Q4 2022 | 125 | $4.23B |
| Q3 2022 | 115 | $3.76B |
| Q2 2022 | 109 | $3.28B |
| Q1 2022 | 107 | $4.27B |
| Q4 2021 | 107 | $3.84B |
| Q3 2021 | 94 | $3.51B |
| Q2 2021 | 82 | $2.65B |
| Q1 2021 | 62 | $1.37B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Cerevel Therapeutics Holdings, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avidity Partners Management LP | 643,000 | $14.0M | 0.57% | +141,800+28.3% | Added |
| Affinity Asset Advisors, LLC | 685,061 | $15.0M | 4.89% | +135,061+24.6% | Added |
| Logos Global Management LP | 700,000 | $15.3M | 2.18% | +700,000 | New |
| Avoro Capital Advisors LLC | 955,555 | $20.9M | 0.33% | +955,555 | New |
| Westfield Capital Management Co LP | 974,483 | $21.3M | 0.14% | +398,949+69.3% | Added |
| Geode Capital Management, LLC | 1,439,277 | $31.4M | 0.00% | +93,248+6.9% | Added |
| Adage Capital Partners GP, L.L.C. | 1,505,976 | $32.9M | 0.07% | +755,976+100.8% | Added |
| Artal Group S.A. | 1,638,858 | $35.8M | 1.56% | 00.0% | Unchanged |
| T. Rowe Price Investment Management, Inc. | 1,824,387 | $39.8M | 0.03% | −35,400−1.9% | Reduced |
| Millennium Management LLC | 2,129,813 | $46.5M | 0.05% | +1,950,018+1,084.6% | Added |
| Rock Springs Capital Management LP | 2,529,116 | $55.2M | 1.48% | +15,200+0.6% | Added |
| Paradigm Biocapital Advisors LP | 2,532,972 | $55.3M | 3.77% | +664,026+35.5% | Added |
| State Street Corp | 2,900,335 | $63.3M | 0.00% | +132,058+4.8% | Added |
| BlackRock Inc. | 4,991,026 | $109.0M | 0.00% | +158,319+3.3% | Added |
| Price T Rowe Associates Inc | 5,503,498 | $120.1M | 0.02% | +278,698+5.3% | Added |
| Vanguard Group Inc | 6,371,376 | $139.1M | 0.00% | +708,826+12.5% | Added |
| Perceptive Advisors LLC | 10,088,385 | $220.2M | 7.40% | 00.0% | Unchanged |
| FMR LLC | 23,623,144 | $515.7M | 0.04% | +129,355+0.6% | Added |
| Bain Capital Investors LLC | 60,199,729 | $1.31B | 42.08% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −1,214,972−100.0% | Sold out |
| Alkeon Capital Management LLC | 0 | $0 | 0.00% | −699,695−100.0% | Sold out |
| Hood River Capital Management LLC | 0 | $0 | 0.00% | −581,886−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −332,597−100.0% | Sold out |
| Boone Capital Management LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −233,680−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −152,117−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −80,912−100.0% | Sold out |
| State of New Jersey Common Pension Fund D | 0 | $0 | 0.00% | −73,492−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −66,390−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −46,000−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −41,292−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Weiss Multi-Strategy Advisers LLC | 0 | $0 | 0.00% | −24,140−100.0% | Sold out |
| Duality Advisers, LP | 0 | $0 | 0.00% | −16,094−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −14,960−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −14,053−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −11,537−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −8,151−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −8,048−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −7,377−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −7,336−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −7,021−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −4,556−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −270−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Toth Financial Advisory Corp | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Tekla Capital Management LLC | – | – | – | – | Not filed |